Prometheus Biosciences Inc. (RXDX:NASDAQ) earned a rating upgrade and target price increase from Oppenheimer based on Prometheus' significant news relayed in the recent management update, analyst J...
- 10 MIN READ
- 12/13/2021
© 2022 Equities News | Equities.com, Inc.